Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Stock and American Depositary Receipts
-
Shares outstanding
-
1,226,467,754
-
Total 13F shares
-
229,055,190
-
Share change
-
-6,327,719
-
Total reported value
-
$11,401,200,286
-
Put/Call ratio
-
117%
-
Price per share
-
$49.79
-
Number of holders
-
474
-
Value change
-
-$309,036,172
-
Number of buys
-
178
-
Number of sells
-
206
Institutional Holders of Sanofi - Common Stock and American Depositary Receipts (SNY) as of Q3 2017
As of 30 Sep 2017,
Sanofi - Common Stock and American Depositary Receipts (SNY) was held by
474 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
229,055,190 shares.
The largest 10 holders included
DODGE & COX, BARROW HANLEY MEWHINNEY & STRAUSS LLC, FRANKLIN RESOURCES INC, Fisher Asset Management, LLC, Boston Partners, BANK OF AMERICA CORP /DE/, FMR LLC, Invesco Ltd., HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC, and MORGAN STANLEY.
This page lists
477
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.